JCB logo
Epitomics: The Rabbit Monoclonal Company
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JCB
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Cell Biol. 10.1083/jcb.200801010
Vince et al.

Figure S1 Fc-TWEAK binds to a large selection of adherent transformed cell lines.

Figure S2 Analysis of TWEAK-induced cIAP1–TRAF2 degradation.

Figure S3 Loss of cIAP1 or TRAF2 results in constitutive activation of noncanonical NF-κB pathway.

Figure S4 Inhibition of TNFα signaling or NF-κB activity provides clonogenic protection to TWEAK-treated cells.

Figure S5 Response of wild-type and knockout MEFs to TWEAK and TNFα treatment.

 





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JCB
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents